BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

News Scripps Research

Monitoring T cells may allow prevention of type 1 diabetes

Read More ➡
News Daily Herald HearldNet

Comment: As Asthma Incidence Rises, Tailor Treatments Better

Read More ➡
News Nature Communications

COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development

Read More
News Journal Science Immunol

New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells

Read More
News Science in Seattle

Science in Seattle: Characterizing T Cell Responses to Enzymatically Modified Beta Cell Neo-Epitopes

Read the publication ➡
News Science in Seattle

Science in Seattle: New Study from BRI and the UW Identify Novel Mechanism of Regulatory T Cells’ Role in Maintaining Immune System Homeostasis

Read More ➡
News Science in Seattle

Science in Seattle: Lupus Nephritis: New Approach Could Pave the Way for Innovative Treatments

Read more ➡
News Science in Seattle

Science in Seattle: A Promising New Approach to Stopping Type 1 Diabetes

Read more ➡
News Journal Exp Med JEM

New Study from Benaroya Research Institute and the University of Washington Identify Novel Mechanism of Regulatory T Cells’ Role in Maintaining Immune System Homeostasis

Read More
News Lancet Planetary Health

NIH study links specific outdoor air pollutants to asthma attacks in urban children

Read More
News Geek Wire

Washington Research Foundation announced its sixth annual cohort of WRF postdoctoral fellows

Read more ➡
News Medical Life Sciences

Pediatric acute myeloid leukemia genetic subtypes with poor outcomes show increased inflammatory cytokine signaling

Read more ➡
News Science in Seattle

Science in Seattle: IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

Read the Publication ➡
News Science in Seattle

Science in Seattle: BRI Awarded $3.4M NIH R01 Grant to Continue Studying Why Immune Responses are Altered in Those with Down Syndrome

Read more ➡
News Helmsley Trust

New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment

Read More